The impact of health policy and advocacy for endocrinology and metabolic diseases extends beyond clinical settings, shaping regulations that improve diabetes care accessibility and affordability. Policymakers work to expand insurance coverage for essential medications, glucose monitoring technologies, and preventive screenings. Advocacy groups push for legislative reforms to address disparities in diabetes management, particularly in low-income and underserved populations. International collaborations aim to standardize guidelines and promote research funding for innovative therapies. By integrating policy-driven approaches with community engagement, healthcare systems can better support individuals with diabetes and endocrine disorders, ensuring equitable access to high-quality care.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti